Evaluation of grip strength and range of motion of the upper limbs in patients with mucopolysaccharidosis VI
DOI:
https://doi.org/10.5935/0104-7795.20150013Keywords:
Mucopolysaccharidosis VI, Upper Extremity, Hand Strength, Physical Therapy ModalitiesAbstract
Objective: The present study aims to evaluate the grip strength and range of motion of the upper limbs of patients with Mucopolysaccharidosis VI in order to observe how these factors can affect and correlate with the activities of daily living. Methods: The sample consisted of 13 patients: 8 males and 5 females, with a mean age of 17.76 years, mean weight of 31.30Kg, and a mean height of 1.17m, who agreed to participate and who met the inclusion criteria. The study was conducted in the state of Pernambuco at the Inborn Errors of Metabolism Treatment Center (Centro de Tratamento de Erros Inatos do Metabolismo), located at the Integrative Medicine Institute (Instituto de Medicina Integral) Prof. Fernando Figueira (IMIP). Range of motion (ROM) measurements of their upper limbs and manual grip strength were collected, and the subjects answered a structured questionnaire. Results: In this study the flexion of the shoulder joint that had the greater impairment mostly did not follow this pattern, since the average ROM for the left arm was 90.38 and 93.38 for the right. The ROM found to be the farthest below the predicted average in the study was for wrist extension in both the left and right limbs. In grip strength assessment, only one individual measured above the predicted average, 9 (69.21%) showed a degree of strength between 0 and 2 pounds (lb) in the right hand and 8 (61.52%) in the left. Conclusion: This study hopes to serve as a means of monitoring the evolution of MPS VI , which can support new studies, evaluation protocols, and motor rehabilitation.
Downloads
References
Dieter T, Matte U, Barbosa F, Schwartz I, Giugliani R. Introduçao às mucopolissacaridosis. Porto Alegre: HCPA; 2002.
Lin SP, Shih SC, Chuang CK, Lee KS, Chen MR, Niu DM, et al. Characterization of pulmonary function impairments in patients with mucopolysaccharidoses- changes with age and treatment. Pediatr Pulmonol. 2014;49(3):277-84. DOI: http://dx.doi.org/10.1002/ppul.22774
Giugliani R. Mucopolysacccharidoses: From understanding to treatment, a century of discoveries. Genet Mol Biol. 2012;35(4 (suppl)):924-31. DOI: http://dx.doi.org/10.1590/S1415-47572012000600006
Mizuno CA, Figueiredo JB, Teza ITV, Taira LGN, Silva TA, Paixao DL, et al. Aspectos clínicos da mucopolissacaridose tipo VI. Rev Soc Bras Clín Méd. 2010;8(4): 356-61.
Giugliani R, Federhen A, Rojas MV, Vieira T, Artigalás O, Pinto LL, et al. Mucopolysaccharidosis I, II, and VI: Brief review and guidelines for treatment. Genet Mol Biol. 2010;33(4):589-604. DOI: http://dx.doi.org/10.1590/S1415-47572010005000093
Cardoso-Santos A, Azevedo AC, Fagondes S, Burin MG, Giugliani R, Schwartz IV. Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): assessment of joint mobility and grip and pinch strength. J Pediatr (Rio J). 2008;84(2):130-5. DOI: http://dx.doi.org/10.2223/JPED.1743
Muenzer J. Overview of the mucopolysaccharidoses. Rheumatology (Oxford). 2011;50 Suppl 5:v4-12. DOI: http://dx.doi.org/10.1093/rheumatology/ker394
Matos MA, Barreto R, Penha CE, Soares C, Costa AA. Amplitude de movimentos em pacientes com mucopolissacaridose (mps-i, mps-ii e mps-vi), após um ano de terapia de reposiçao enzimática. Rev baiana saúde pública. 2010;34(Supl 1):60-1.
Vieira TA. História natural das mucopolissacaridoses: uma investigaçao da trajetória dos pacientes desde o nascimento até o diagnóstico [dissertaçao]. Porto Alegre: Universidade Federal do Rio Grande do Sul; 2007.
Giugliani R, Federhen A, Muñoz Rojas MV, Vieira TA, Artigalás O, Pinto LL, et al. Enzyme replacement therapy for mucopolysaccharidoses I, II and VI: recommendations from a group of Brazilian F experts. Rev Assoc Med Bras. 2010;56(3):271-7. DOI: http://dx.doi.org/10.1590/S0104-42302010000300009
Rocha JSM, Bonorandi AD, Oliveira LS, Silva MNS, Silva VF. Avaliaçao do desempenho motor em crianças com mucopolissacaridose II. Cad Ter Ocup UFSCar. 2012;20(3):403-12. DOI: http://dx.doi.org/10.4322/cto.2012.040
Morini SR. Caracterizaçao do sistema músculo-esquelético em indivíduos com mucopolissacaridoses tipo II: alguns aspectos cinéticos e consequências funcionais [dissertaçao]. Campinas: Universidade Estadual de Campinas; 2007.
Mathiowetz V, Wiemer DM, Federman SM. Grip and pinch strength: norms for 6- to 19-year-olds. Am J Occup Ther. 1986 ;40(10):705-11. DOI: http://dx.doi.org/10.5014/ajot.40.10.705
Mathiowetz V, Kashman N, Volland G, Weber K, Dowe M, Rogers S. Grip and pinch strength: normative data for adults. Arch Phys Med Rehabil. 1985;66(2):69-74.
Pereira JO, Gabriela M, Moreira DA, Palazzo VC. Mucopolissacaridose tipo VI: evoluçao natural, importância diagnóstica e terapêutica. Rev Neurocienc. 2011;19(2):329-38.
Aslam R, van Bommel AC, Hendriksz CJ, Jester A. Subjective and Objective Assessment of Hand Function in Mucopolysaccharidosis IVa Patients. JIMD Rep. 2013;9:59-65.
Guarany NR, Schwartz IV, Guarany FC, Giugliani R. Functional capacity evaluation of patients with mucopolysaccharidosis. J Pediatr Rehabil Med. 2012;5(1):37-46.
Tylki-Szymanska A, Marucha J, Jurecka A, Syczewska M, Czartoryska B. Efficacy of recombinant human alpha-L-iduronidase (laronidase) on restricted range of motion of upper extremities in mucopolysaccharidosis type I patients. J Inherit Metab Dis. 2010;33(2):151-7. DOI: http://dx.doi.org/10.1007/s10545-010-9059-9
Downloads
Published
Issue
Section
License
Copyright (c) 2015 Acta Fisiátrica
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
